AzTrials
AzTrials

Patient-Controlled AnalgesiaNCT03221491

Comparison of Patient-Controlled Analgesia With Different Background Infusion

A study of Patient-Controlled Analgesia, run by Weifeng Tu at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, the investigators investigated the efficacy, usefulness and analgesic consumption of three different patient-controlled analgesia(PCA) programmes:bolus dose alone without background infusion, bolus dose with low background infusion and bolus dose with high background infusion to evaluate postoperative… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Patient-Controlled Analgesia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteChina
Study dates
1 Jul 2016to 30 Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists(ASA) Ⅰ-Ⅱ patient undergoing laparoscopic colorectal surgery
  • Written informed consent from the patient or the relatives of the participating patient.
  • BMI:18~30kg/m2

Who cannot join

  • Mental illness or cannot communicate.;
  • A second operation during the study;
  • Lung infection or sleep apnea syndrome;
  • Renal failure;
  • Alcohol or drug abuse;
  • Already taking gabapentin, pregabalin, benzodiazepin or antidepression drug;
  • Long-term use of analgesics,sedatives or non steroidal anti-inflammatory drugs history .

Trial locations and contacts

1 site in 1 country.

China1 site
  • Guangzhou General Hospital of Guangzhou Military Command

    Guangzhou, Guangdong, 510010

Other trials in China

About this study

Official title: Comparison of Intravenous Patient-Controlled Analgesia With Different Background Infusion After Colorectal Surgery

In this study, the investigators investigated the efficacy, usefulness and analgesic consumption of three different patient-controlled analgesia(PCA) programmes:bolus dose alone without background infusion, bolus dose with low background infusion and bolus dose with high background infusion to evaluate postoperative analgesia for patients after laparoscopic colorectal surgery.

Read the detailed description

There have been many studies using patient-controlled analgesia (PCA) and opioids for postoperative analgesia.Patient-controlled analgesia with opioids is now widely used after surgery for the treatment of acute postoperative pain. This technique provides effective pain treatment, adjusts the dose according to personal need and keeps plasma analgesic levels at a constant level,but the incidence of opioid-induced side-effects still be reported frequently.A proper PCA programme may increase efficiency of analgesic and decrease incidence of analgesic-induced side-effects.

In this study, 90 patients who is undergoing elective laparoscopic colorectal surgery will be randomly allocated into three groups (no background infusion group(Group B0),low background infusion group(Group B1) and high background infusion group(Group B2)). Patients in all groups will be given a patient-controlled analgesia (PCA) pump in post anesthetic recovery unit (PACU) after surgery.The PCA programme of Group B0 is dezocine 0.6mg/kg, flubiprofen 3mg/kg, diluted into 120ml and administer at a background infusion of 0ml/h, and a bolus of 4ml, with a lock-out of 15min. The PCA protocol of Group B1 is dezocine 0.6mg/kg,flubiprofen 3mg/k diluted into 120ml and administer at a background infusion of 1ml/h, and a bolus of 2ml, with a lock-out of 15min.The PCA protocol of Group B2 is dezocine 0.6mg/kg,flubiprofen 3mg/k diluted into 120ml and administer at a background infusion of 2ml/h, and a bolus of 2ml, with a lock-out of 15min.

Being tested
Patient-Controlled Analgesia(PCA)
Keywords
Analgesia, Colorectal Surgery, Background Infusion
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient-Controlled Analgesia(PCA)Device

    Patients receive analgesic regimens using Patient-Controlled Analgesia(PCA) with different background infusion.

Study groups in NCT03221491
Study groupRoleWhat they receive
No Background Infusion Group(Group B0)ExperimentalPatients in Group B0 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 0ml/h.
Receives: Device: Patient-Controlled Analgesia(PCA)
Low Background Infusion Group(Group B1)ExperimentalPatients in Group B1 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 1ml/h.
Receives: Device: Patient-Controlled Analgesia(PCA)
High Background Infusion Group(Group B2)ExperimentalPatients in Group B2 receive analgesic regimens using Patient-Controlled Analgesia(PCA) with background infusion 2ml/h.
Receives: Device: Patient-Controlled Analgesia(PCA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dezocine consumption by patient-controlled analgesia

    The total consumption of dezocine during 24 hours after surgery are recorded.

    Measured: At 24 hours after surgery

Secondary outcomes (3)
  1. The incidence rates of postoperative nausea and vomiting (PONV)

    Measure whether nausea and vomiting exist and the level of severity.

    Measured: At 24 hours and 48 hours after surgery

  2. Change in ramsay sedation score

    Measure sedation level by using ramsay sedation score.

    Measured: At 0, 2, 4, 8, 24, 48 and 72 hours after surgery

  3. Change in pain score

    Pain scores at rest and movement are evaluated with a numeric rating scale (NRS)

    Measured: At 0, 2, 4, 8, 24, 48 and 72 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2017
  2. Study start1 Jul 2016
  3. Primary completion30 Jun 2017
  4. Study completion30 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03221491
Sponsor's protocol ID
Different Background Infusion
Status last verified
Jul 2017
First submitted
16 Jul 2017
Last updated
21 Jul 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Doyle E, Harper I, Morton NS. Patient-controlled analgesia with low dose background infusions after lower abdominal surgery in children. Br J Anaesth. 1993 Dec;71(6):818-22. doi: 10.1093/bja/71.6.818.

    PubMed 8280546
  • Yildiz K, Tercan E, Dogru K, Ozkan U, Boyaci A. Comparison of patient-controlled analgesia with and without a background infusion after appendicectomy in children. Paediatr Anaesth. 2003 Jun;13(5):427-31. doi: 10.1046/j.1460-9592.2003.01061.x.

    PubMed 12791117
  • White I, Ghinea R, Avital S, Chazan S, Dolkart O, Weinbroum AA. Morphine at "sub-analgesic" background infusion rate plus low-dose PCA bolus control pain better and is as safe as twice a bolus-only PCA regimen: a randomized, double blind study. Pharmacol Res. 2012 Aug;66(2):185-91. doi: 10.1016/j.phrs.2012.03.016. Epub 2012 Apr 6.

    PubMed 22504462
  • Hayes J, Dowling JJ, Peliowski A, Crawford MW, Johnston B. Patient-Controlled Analgesia Plus Background Opioid Infusion for Postoperative Pain in Children: A Systematic Review and Meta-Analysis of Randomized Trials. Anesth Analg. 2016 Oct;123(4):991-1003. doi: 10.1213/ANE.0000000000001244.

    PubMed 27065359

Questions about this trial

What is this clinical trial studying?

A study of Patient-Controlled Analgesia, run by Weifeng Tu at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dezocine consumption by patient-controlled analgesia (time frame: At 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03221491, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in